共 103 条
[1]
Ellis M(2001)Invasive fungal infections: evolving challenges for diagnosis and treatment Mol Immunol 28 947-57
[2]
Guery BP(2009)Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I Epidemiology and Diagnosis Intensive Care Med 35 55-62
[3]
Arendrup MC(2008)A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults Clin Infect Dis 46 890-6
[4]
Auzinger G(2008)Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial Ann Intern Med 149 83-90
[5]
McMullan R(2005)Delaying the empiric treatment of Antimicrob Agents Chemother 49 3640-5
[6]
Metwally L(2006) bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality Clin Infect Dis 43 25-31
[7]
Coyle PV(2007)Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study J Antimicrob Chemother 60 613-8
[8]
Schuster MG(2002)Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Am J Med 113 480-5
[9]
Edwards JE(2000) species infections Infect Dis Clin Pract 9 169-75
[10]
Sobel JD(2001)Effects of nosocomial candidemia on outcomes of critically ill patients Ann Surg 233 542-8